The rs3761548 polymorphism of FOXP3 is a protective genetic factor against allergic rhinitis in the Hungarian female population

Human Immunology

Volumn 72, Issue 10, 2011, Pages 926-929

  Fodor, Eszter ^a   Garaczi, Edina ^a   Polyánka, Hilda ^a   Koreck, Andrea ^a,b   Kemény, Lajos ^a   Széll, Márta ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Allergic rhinitis; FOXP3; Polymorphism; Protective genetic factor

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ALLELE; ALLERGIC RHINITIS; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HETEROZYGOTE; HUMAN; HUNGARY; IMMUNITY; MAJOR CLINICAL STUDY; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; RAGWEED POLLEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CHILD; DNA FINGERPRINTING; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HUNGARY; MALE; MIDDLE AGED; PHYLOGEOGRAPHY; POLYMORPHISM, SINGLE NUCLEOTIDE; RHINITIS, ALLERGIC, PERENNIAL; SEX FACTORS;

EID: 80052961588     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.06.011     Document Type: Article

References (30)

1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
2. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2:389-400.
3. Miyara M., Wing K., Sakaguchi S. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J Allergy Clin Immunol 2009, 123:749-755.
4. Stock P., DeKruyff R.H., Umetsu D.T. Inhibition of the allergic response by regulatory T cells. Curr Opin Allergy Clin Immunol 2006, 6:12-16.
5. Torgerson T.R., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007, 120:744-750.
6. Karlsson M.R., Rugtveit J., Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004, 199:1679-1688.
7. Hauet-Broere F., Unger W.W., van Berkel L.A., Garssen J., Hoijer M.A., Kraal G., et al. New cohorts of naive T cells exacerbate ongoing allergy but can be suppressed by regulatory T cells. Allergy 2005, 60:1530-1536.
8. Hadeiba H., Locksley R.M. Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J Immunol 2003, 170:5502-5510.
9. Joetham A., Takeda K., Taube C., Miyahara N., Matsubara S., Koya T., et al. Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol 2007, 178:1433-1442.
10. Ling E.M., Smith T., Nguyen X.D., Pridgeon C., Dallman M., Arbery J., et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004, 363:608-615.
11. Jutel M., Akdis M., Budak F., Aebischer-Casaulta C., Wrzyszcz M., Blaser K., et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003, 33:1205-1214.
12. Durham S.R., Walker S.M., Varga E.M., Jacobson M.R., O'Brien F., Noble W., et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999, 341:468-475.
13. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
14. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
15. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003, 4:337-342.
16. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000, 106:R75-R81.
17. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
18. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27:18-20.
19. Bacchetta R., Passerini L., Gambineri E., Dai M., Allan S.E., Perroni L., et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006, 116:1713-1722.
20. Bassuny W.M., Ihara K., Sasaki Y., Kuromaru R., Kohno H., Matsuura N., et al. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 2003, 55:149-156.
21. Park O., Grishina I., Leung P.S., Gershwin M.E., Prindiville T. Analysis of the Foxp3/scurfin gene in Crohn's disease. Ann N Y Acad Sci 2005, 1051:218-228.
22. Owen C.J., Eden J.A., Jennings C.E., Wilson V., Cheetham T.D., Pearce S.H. Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J Mol Endocrinol 2006, 37:97-104.
23. Nik Tavakoli N., Hambly B.D., Sullivan D.R., Bao S. Forkhead box protein 3: essential immune regulatory role. Int J Biochem Cell Biol 2008, 40:2369-2373.
24. Zhang L., Zhang Y., Desrosiers M., Wang C., Zhao Y., Han D. Genetic association study of FOXP3 polymorphisms in allergic rhinitis in a Chinese population. Hum Immunol 2009, 70:930-934.
25. Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147-S334. Aria Workshop Group, World Health Organization.
26. Bousquet J., Khaltaev N., Cruz A.A., et al. Allergic rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and allergen). Allergy 2008, 63(suppl 86):8-160.
27. Dávila I., Mullol J., Ferrer M., Bartra J., del Cuvillo A., Montoro J., et al. Genetic aspects of allergic rhinitis. J Investig Allergol Clin Immunol 2009, 19(suppl 1):25-31.
28. Ferguson L.R., Huebner C., Petermann I., Gearry R.B., Barclay M.L., Demmers P., et al. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroenterol 2008, 14:4652-4661.
29. van Heel D.A., Udalova I.A., De Silva A.P., McGovern D.P., Kinouchi Y., Hull J., et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet 2002, 11:1281-1289.
30. Szabo K., Tax G., Teodorescu-Brinzeu D., Koreck A., Kemeny L. TNFalpha gene polymorphisms in the pathogenesis of acne vulgaris. Arch Dermatol Res 2011, 303:19-27.